Sangamo and Pfizer Announce Phase 1/2 Interim Data for Investigational Hemophilia A Gene Therapy

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/28/2026

1. ON
2. SYNA
3. SPY
4. MU
5. AAPL
6. VEON
7. SPCX
8. DRI
9. NVDA
10. FDXF

Go back to Sangamo and Pfizer Announce Phase 1/2 Interim Data for Investigational Hemophilia A Gene Therapy

Sangamo Therapeutics (SGMO) Continues to Gain, Now Up 50%

April 2, 2019 8:39 AM EDT

Sangamo Therapeutics (NASDAQ: SGMO) Continues to Gain, Now Up 50%

... More

Sangamo Therapeutics (SGMO) Hits Pre-Market High, Up 26%

April 2, 2019 8:09 AM EDT

Sangamo Therapeutics (NASDAQ: SGMO) Hits Pre-Market High, Up 26%

... More